Maurer MS, Schwartz JH, Gundapaneni B, et al. Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy. N Engl J Med 2018 ; 379 : 1007.
González-López E, Gagliardi C, Dominguez F, et al. Clinical characteristics of wild-type transthyretin cardiac amyloidosis : disproving myths. Eur Heart J 2017 ; 38 : 1895.
Connors LH, Sam F, Skinner M, et al. Heart Failure Resulting From Age-Related Cardiac Amyloid Disease Associated With Wild-Type Transthyretin : A Prospective, Observational Cohort Study. Circulation 2016 ; 133 : 282.
Pinney JH, Whelan CJ, Petrie A, et al. Senile systemic amyloidosis : clinical features at presentation and outcome. J Am Heart Assoc 2013 ; 2 : e000098.